Articles

Cancer Drugs Fund budget increased – but pharma prices to be challenge…

28th August 2014

Cancer Drugs Fund budget increased – but pharma prices to be challengedAndrew McConaghie

England's Cancer Drugs Fund is to see its annual budget increased by 40 per cent – but 'excessively priced' drugs could be removed from the list if companies refuse to... Read more

The Game Changer – 3D in Healthcare Apps

28th August 2014

The Game Changer – 3D in Healthcare AppsAshish Khera

Are healthcare apps really changing the healthcare landscape? Ashish Khera discusses the trends, the extent to which apps are affecting the industry and the use of 3D in anatomy-related medical... Read more

The case for one global SOP for medical publications

27th August 2014

The case for one global SOP for medical publicationsRussell Traynor

As medical publishing becomes increasingly global, it makes sense to institute one standard operating procedure to maintain consistency in all markets. However, with budget constraints and regional differences, this is... Read more

Ebola 2014: lessons for global healthcare

26th August 2014

Ebola 2014: lessons for global healthcareChris McCourt

The current Ebola outbreak has brought to the fore the importance of culture in healthcare, particularly in relation to gaining multilingual informed consent for clinical trials and building trust in... Read more

News

BMS hep C drug approved in Europe

28th August 2014

BMS hep C drug approved in EuropeStaff reporter

The news in hepatitis C in recent months has all been about Gilead's record-smashing launch of Sovaldi and whether rival AbbVie will be able to close the gap on the... Read more

NICE wants more cost evidence on BI’s diabetes drug

28th August 2014

NICE wants more cost evidence on BI’s diabetes drugLinda Banks

More evidence on the cost-effectiveness of Boehringer Ingelheim's type 2 diabetes drug empagliflozin has been requested by health watchdog NICE in new draft guidance.Empagliflozin (marketed as Jardiance) is one of... Read more

StemCells turning a corner?

27th August 2014

StemCells turning a corner?Staff reporter

The path seems to be clearing in front of US biotech StemCells as it advances cell-based therapies for blindness and spinal cord injury (SCI) into mid-stage clinical testing.StemCells completed a... Read more

ViiV gets US approval for Atripla rival Triumeq

26th August 2014

ViiV gets US approval for Atripla rival Triumeq

Armed with FDA approval for its triple HIV drug Triumeq, ViiV Healthcare can now start to challenge rival Gilead Sciences for a larger slice of the antiretroviral drugs market in... Read more

Audio & Video

Patient Opinion Leaders: Andrew Schorr

 

As a cancer survivor and passionate patient advocate, Andrew Schorr typifies the concept of a Patient Opinion Leader (POL). He is a contributor to the... View more

View the recorded webinar - The future o…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

Is there common ground for engagement be…

Doctors net webinar

 

The growth of online networks for doctors has been accompanied by recognition from the pharmaceutical industry that these digital meeting grounds can be... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

Cubist files novel antibiotic in Europe

A novel antibiotic combination from US company Cubist has been filed with the European Union regulator the EMA.<... Read more

News

Roche to pay $8.3 billion for InterMune

Roche has swooped to acquire InterMune, the US biotech company behind the potential blockbuster treatment pir... Read more

News

Pfizer casting elsewhere for overseas M&A?

A series of positive pipeline updates could make the asking price for AstraZeneca (AZ) very steep if Pfizer m... Read more

News

Behavioural economics: a powerful tool to examine decision-making

Behavioural economics can be used to frame market researchers' questions so as to ensure respondents' answers are th... Read more

Articles

Lilly lifted by psoriasis results

Lilly has unveiled strong phase III results for its psoriasis drug ixekizumab, showing it to be superior to P... Read more

News

AstraZeneca extends cancer gene sequencing collaborations

AstraZeneca (AZ) is to collaborate with gene sequencing company, Illumina, to develop its next generation sequen... Read more

News